Kiltearn Partners LLP Acquires Shares of 37,314 HCA Healthcare, Inc. $HCA

Kiltearn Partners LLP bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 37,314 shares of the company’s stock, valued at approximately $14,548,000. HCA Healthcare makes up about 3.5% of Kiltearn Partners LLP’s portfolio, making the stock its 9th largest position.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCA. Matters Capital LLC purchased a new stake in shares of HCA Healthcare in the second quarter worth approximately $1,716,000. Clear Harbor Asset Management LLC bought a new stake in HCA Healthcare during the second quarter worth $404,000. Bank of Nova Scotia bought a new position in HCA Healthcare during the 2nd quarter valued at $18,473,000. Kendall Capital Management bought a new stake in shares of HCA Healthcare in the 2nd quarter worth $1,398,000. Finally, Elevation Point Wealth Partners LLC bought a new position in shares of HCA Healthcare during the second quarter valued at about $8,461,000. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have commented on HCA shares. Cantor Fitzgerald decreased their price objective on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research note on Tuesday, July 7th. Stephens decreased their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Weiss Ratings cut HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Argus lowered their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Finally, Robert W. Baird reduced their price target on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating for the company in a research report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $462.64.

HCA Healthcare Price Performance

Shares of HCA opened at $429.08 on Friday. The firm has a market cap of $92.90 billion, a PE ratio of 14.36, a PEG ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The stock’s fifty day moving average price is $397.16 and its two-hundred day moving average price is $444.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the firm posted $6.84 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.